Articles By Anuja Singh
Can a Single Injection Change Everything? Novartis’s Itvisma Wins EU Approval for Broader SMA…
Key Highlights Closing a Long-Standing Treatment Gap Itvisma’s approval extends gene replacement therapy to an SMA population that…
ByCan Novartis’s Up to $1.5 Billion Acquisition of Myricx Bio Unlock a New Generation…
Key Highlights A Landmark Exit for Early-Stage Science Brandon Capital’s exit from Myricx Bio represents one of its…
Can Novo Nordisk’s Newly EU-Approved Wegovy Pill Make Weight Loss Treatment as Simple as…
Key Highlights A Landmark Shift From Injection to Tablet The European Commission’s authorization marks the first time a…
Is Eli Lilly’s Reported $2 Billion Pursuit of AtaiBeckley About to Redefine the Future…
Key Highlights A Premium Bet on Psychedelic Innovation Eli Lilly is negotiating a takeover of AtaiBeckley at a…
Can Aspira Women’s Health and Cleveland Clinic’s New AI Alliance Rewrite the Rules for…
Key Highlights A Strategic Alliance Built for Scale Aspira Women’s Health and Cleveland Clinic have entered a comprehensive…
Will Big Pharma’s Billion-Dollar AI Investments Reshape the US$2 Trillion Pharmaceutical Industry Faster Than…
Key Highlights The AI Investment Race Has Officially Begun Artificial intelligence has rapidly evolved from an experimental technology…
Can a Single Injection Change Everything? Novartis’s Itvisma Wins EU Approval for Broader SMA…
Key Highlights Closing a Long-Standing Treatment Gap Itvisma’s approval extends gene replacement therapy to an SMA population that…
Can Novartis’s Up to $1.5 Billion Acquisition of Myricx Bio Unlock a New Generation…
Key Highlights A Landmark Exit for Early-Stage Science Brandon Capital’s exit from Myricx Bio represents one of its…
Can Novo Nordisk’s Newly EU-Approved Wegovy Pill Make Weight Loss Treatment as Simple as…
Key Highlights A Landmark Shift From Injection to Tablet The European Commission’s authorization marks the first time a…
Is Eli Lilly’s Reported $2 Billion Pursuit of AtaiBeckley About to Redefine the Future…
Key Highlights A Premium Bet on Psychedelic Innovation Eli Lilly is negotiating a takeover of AtaiBeckley at a…
Can Aspira Women’s Health and Cleveland Clinic’s New AI Alliance Rewrite the Rules for…
Key Highlights A Strategic Alliance Built for Scale Aspira Women’s Health and Cleveland Clinic have entered a comprehensive…
Will Big Pharma’s Billion-Dollar AI Investments Reshape the US$2 Trillion Pharmaceutical Industry Faster Than…
Key Highlights The AI Investment Race Has Officially Begun Artificial intelligence has rapidly evolved from an experimental technology…